• DOI:10.1002/jcph.1557
Corpus ID: 208019237

A Review of Cannabis and Interactions With Anticoagulant and Antiplatelet Agents

@article{Greger2019ARO,
  title={A Review of Cannabis and Interactions With Anticoagulant and Antiplatelet Agents},
  author={Jessica Greger and V. Bates and Laszlo L Mechtler and F. Gengo},
  journal={The Journal of Clinical Pharmacology},
  year={2019},
  volume={60}
}

Jessica Greger, V. Bates, +1 author F. Gengo

Published 2019

Medicine

The Journal of Clinical Pharmacology

Legalization of medical cannabis has occurred in 33 states and the District of Columbia, and recreational use has increased exponentially since 2013. As a result, it is important to understand how cannabis interacts with other drugs and has potential risks for patients on concomitant medications. Components of medical cannabis can inhibit or compete for several cytochrome P450 (CYP) hepatic isoenzymes, UDP‐glucuronosyltransferases, and P‐glycoprotein. These enzymes and transporters are involved… CONTINUE READING

View on Wiley

ncbi.nlm.nih.gov

Save to Library

Create Alert

Cite

Launch Research Feed